Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Adherence to Clinical Trial Supported Evaluation of Optic Neuritis.

Meer E, Shindler KS, Yu Y, VanderBeek BL.

Ophthalmic Epidemiol. 2019 May 29:1-8. doi: 10.1080/09286586.2019.1621352. [Epub ahead of print]

PMID:
31140885
2.

Utility of Magnetic Resonance Imaging Features for Improving the Diagnosis of Idiopathic Intracranial Hypertension Without Papilledema.

Mallery RM, Rehmani OF, Woo JH, Chen YJ, Reddi S, Salzman KL, Pinho MC, Ledbetter L, Tamhankar MA, Shindler KS, Digre KB, Friedman DI, Liu GT.

J Neuroophthalmol. 2019 Feb 26. doi: 10.1097/WNO.0000000000000767. [Epub ahead of print]

PMID:
30829949
3.

Effects of Varying Intranasal Treatment Regimens in ST266-Mediated Retinal Ganglion Cell Neuroprotection.

Khan RS, Dine K, Wessel H, Brown L, Shindler KS.

J Neuroophthalmol. 2019 Jun;39(2):191-199. doi: 10.1097/WNO.0000000000000760.

PMID:
30829880
4.

Intracranial Inoculation Is More Potent Than Intranasal Inoculation for Inducing Optic Neuritis in the Mouse Hepatitis Virus-Induced Model of Multiple Sclerosis.

Singh M, Khan RS, Dine K, Das Sarma J, Shindler KS.

Front Cell Infect Microbiol. 2018 Sep 4;8:311. doi: 10.3389/fcimb.2018.00311. eCollection 2018.

5.

RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome.

Grinblat GA, Khan RS, Dine K, Wessel H, Brown L, Shindler KS.

Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2470-2477. doi: 10.1167/iovs.18-24096.

6.

Retrospective, Multicenter Comparison of the Clinical Presentation of Patients Presenting With Diplopia From Giant Cell Arteritis vs Other Causes.

Ross AG, Jivraj I, Rodriguez G, Pistilli M, Chen JJ, Sergott RC, Moster M, Sheldon CA, Liu GT, Foroozan R, Ko MW, Francis CE, Williams ZR, Lee AG, McClelland CM, Shindler KS, Yalamanchili S, Osborne B, Hedges TR 3rd, Van Stavern GP, Puckett E, Rigi M, García-Basterra I, Tamhankar MA.

J Neuroophthalmol. 2019 Mar;39(1):8-13. doi: 10.1097/WNO.0000000000000656.

PMID:
29697441
7.

SIRT1 and NRF2 Gene Transfer Mediate Distinct Neuroprotective Effects Upon Retinal Ganglion Cell Survival and Function in Experimental Optic Neuritis.

McDougald DS, Dine KE, Zezulin AU, Bennett J, Shindler KS.

Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1212-1220. doi: 10.1167/iovs.17-22972.

8.

Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss.

Huang H, Miao L, Liang F, Liu X, Xu L, Teng X, Wang Q, Ridder WH 3rd, Shindler KS, Sun Y, Hu Y.

Cell Death Dis. 2017 Jul 20;8(7):e2936. doi: 10.1038/cddis.2017.329.

9.

Factors Associated with Occurrence of Radiation-induced Optic Neuropathy at "Safe" Radiation Dosage.

Doroslovački P, Tamhankar MA, Liu GT, Shindler KS, Ying GS, Alonso-Basanta M.

Semin Ophthalmol. 2018;33(4):581-588. doi: 10.1080/08820538.2017.1346133. Epub 2017 Jul 13.

PMID:
28704158
10.

Orbital ultrasonography in the diagnosis of neoplastic extraocular muscle enlargement.

Greaves GH, Livingston K, Liu GT, Shindler KS, Volpe NJ, Pistilli M, Mehta S, Tamhankar MA.

Orbit. 2017 Oct;36(5):317-321. doi: 10.1080/01676830.2017.1337173. Epub 2017 Jul 13.

PMID:
28704144
11.

Mitochondrial Uncoupler Prodrug of 2,4-Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis.

Khan RS, Dine K, Geisler JG, Shindler KS.

Oxid Med Cell Longev. 2017;2017:7180632. doi: 10.1155/2017/7180632. Epub 2017 Jun 7.

12.

In Vivo Effects of Retrobulbar Bimatoprost Injection on Orbital Fat.

Eftekhari K, Vagefi MR, Lee V, Hui JZ, Zhu M, Dine K, Anderson RL, Koeberlein B, Sulaimankutty R, Shindler KS.

Ophthalmic Plast Reconstr Surg. 2018 May/Jun;34(3):201-204. doi: 10.1097/IOP.0000000000000907.

13.

Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.

Khan RS, Dine K, Bauman B, Lorentsen M, Lin L, Brown H, Hanson LR, Svitak AL, Wessel H, Brown L, Shindler KS.

Sci Rep. 2017 Jan 31;7:41768. doi: 10.1038/srep41768.

14.

Correction to 'New genetic and morphological evidence suggests a single hoaxer created 'Piltdown Man''.

De Groote I, Flink LG, Abbas R, Bello SM, Burgio L, Buck LT, Dean C, Freyne A, Higham T, Jones CG, Kruszynski R, Lister A, Parfitt SA, Skinner MM, Shindler K, Stringer CB.

R Soc Open Sci. 2016 Oct 12;3(10):160679. eCollection 2016 Oct.

15.

New genetic and morphological evidence suggests a single hoaxer created 'Piltdown man'.

De Groote I, Flink LG, Abbas R, Bello SM, Burgia L, Buck LT, Dean C, Freyne A, Higham T, Jones CG, Kruszynski R, Lister A, Parfitt SA, Skinner MM, Shindler K, Stringer CB.

R Soc Open Sci. 2016 Aug 10;3(8):160328. eCollection 2016 Aug. Erratum in: R Soc Open Sci. 2016 Oct 12;3(10 ):160679.

16.

Ophthalmic presentation of giant cell arteritis in African-Americans.

Garrity ST, Pistilli M, Vaphiades MS, Richards NQ, Subramanian PS, Rosa PR, Lam BL, Osborne BJ, Liu GT, Duncan KE, Shin RK, Volpe NJ, Shindler KS, Lee MS, Moster ML, Tracey EH, Cuprill-Nilson SE, Tamhankar MA.

Eye (Lond). 2017 Jan;31(1):113-118. doi: 10.1038/eye.2016.199. Epub 2016 Sep 16.

17.

Demyelinating strain of mouse hepatitis virus infection bridging innate and adaptive immune response in the induction of demyelination.

Biswas K, Chatterjee D, Addya S, Khan RS, Kenyon LC, Choe A, Cohrs RJ, Shindler KS, Das Sarma J.

Clin Immunol. 2016 Sep;170:9-19. doi: 10.1016/j.clim.2016.07.004. Epub 2016 Jul 6.

PMID:
27394164
18.

A magpie with a card-index mind - Charles Davies Sherborn 1861-1942.

Shindler K.

Zookeys. 2016 Jan 7;(550):33-56. doi: 10.3897/zookeys.550.9975. eCollection 2016.

19.

Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus.

Kenyon LC, Biswas K, Shindler KS, Nabar M, Stout M, Hingley ST, Grinspan JB, Das Sarma J.

Front Cell Neurosci. 2015 Dec 22;9:488. doi: 10.3389/fncel.2015.00488. eCollection 2015.

20.

Acute optic neuritis: Unmet clinical needs and model for new therapies.

Galetta SL, Villoslada P, Levin N, Shindler K, Ishikawa H, Parr E, Cadavid D, Balcer LJ.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e135. doi: 10.1212/NXI.0000000000000135. eCollection 2015 Aug. Review.

21.

Plasticity of the human visual system after retinal gene therapy in patients with Leber's congenital amaurosis.

Ashtari M, Zhang H, Cook PA, Cyckowski LL, Shindler KS, Marshall KA, Aravand P, Vossough A, Gee JC, Maguire AM, Baker CI, Bennett J.

Sci Transl Med. 2015 Jul 15;7(296):296ra110. doi: 10.1126/scitranslmed.aaa8791.

22.

Histologic Evidence of Orbital Inflammation from Retrobulbar Alcohol and Chlorpromazine Injection: A Clinicopathologic Study in Human & Rat Orbits.

Eftekhari K, Shindler KS, Lee V, Dine K, Eckstein LA, Vagefi MR.

Ophthalmic Plast Reconstr Surg. 2016 Jul-Aug;32(4):302-4. doi: 10.1097/IOP.0000000000000512.

23.

Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.

Wu GF, Parker Harp CR, Shindler KS.

Curr Immunol Rev. 2015;11(2):85-92. doi: 10.2174/1573395511666150707181644.

24.

Mouse hepatitis virus infection upregulates genes involved in innate immune responses.

Chatterjee D, Addya S, Khan RS, Kenyon LC, Choe A, Cohrs RJ, Shindler KS, Sarma JD.

PLoS One. 2014 Oct 31;9(10):e111351. doi: 10.1371/journal.pone.0111351. eCollection 2014.

25.
26.

The role of orbital ultrasonography in distinguishing papilledema from pseudopapilledema.

Carter SB, Pistilli M, Livingston KG, Gold DR, Volpe NJ, Shindler KS, Liu GT, Tamhankar MA.

Eye (Lond). 2014 Dec;28(12):1425-30. doi: 10.1038/eye.2014.210. Epub 2014 Sep 5.

27.

HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.

Khan RS, Dine K, Luna E, Ahlem C, Shindler KS.

Invest Ophthalmol Vis Sci. 2014 Aug 19;55(9):5744-51. doi: 10.1167/iovs.14-14672.

28.

SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease.

Khan RS, Dine K, Das Sarma J, Shindler KS.

Acta Neuropathol Commun. 2014 Jan 2;2:3. doi: 10.1186/2051-5960-2-3.

29.

Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 mice.

Kishore A, Kanaujia A, Nag S, Rostami AM, Kenyon LC, Shindler KS, Das Sarma J.

Biomed Res Int. 2013;2013:589048. doi: 10.1155/2013/589048. Epub 2013 Aug 28.

30.

SIRT1 promotes RGC survival and delays loss of function following optic nerve crush.

Zuo L, Khan RS, Lee V, Dine K, Wu W, Shindler KS.

Invest Ophthalmol Vis Sci. 2013 Jul 26;54(7):5097-102. doi: 10.1167/iovs.13-12157.

31.

Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity.

Chen Y, Khan RS, Cwanger A, Song Y, Steenstra C, Bang S, Cheah JH, Dunaief J, Shindler KS, Snyder SH, Kim SF.

J Neurosci. 2013 Feb 20;33(8):3582-7. doi: 10.1523/JNEUROSCI.1497-12.2013.

32.

SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.

Khan RS, Fonseca-Kelly Z, Callinan C, Zuo L, Sachdeva MM, Shindler KS.

Front Cell Neurosci. 2012 Dec 31;6:63. doi: 10.3389/fncel.2012.00063. eCollection 2012.

33.

Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.

Fonseca-Kelly Z, Nassrallah M, Uribe J, Khan RS, Dine K, Dutt M, Shindler KS.

Front Neurol. 2012 May 24;3:84. doi: 10.3389/fneur.2012.00084. eCollection 2012.

34.

In vivo detection of experimental optic neuritis by pupillometry.

Shindler KS, Revere K, Dutt M, Ying GS, Chung DC.

Exp Eye Res. 2012 Jul;100:1-6. doi: 10.1016/j.exer.2012.04.005. Epub 2012 Apr 24.

35.

The diagnostic and economic yield of neuroimaging in neuro-ophthalmology.

Mehta S, Loevner LA, Mikityansky I, Langlotz C, Ying GS, Tamhankar MA, Shindler KS, Volpe NJ.

J Neuroophthalmol. 2012 Jun;32(2):139-44. doi: 10.1097/WNO.0b013e31824e3753.

PMID:
22510684
36.

AAV2 gene therapy readministration in three adults with congenital blindness.

Bennett J, Ashtari M, Wellman J, Marshall KA, Cyckowski LL, Chung DC, McCague S, Pierce EA, Chen Y, Bennicelli JL, Zhu X, Ying GS, Sun J, Wright JF, Auricchio A, Simonelli F, Shindler KS, Mingozzi F, High KA, Maguire AM.

Sci Transl Med. 2012 Feb 8;4(120):120ra15. doi: 10.1126/scitranslmed.3002865.

37.

Mycophenolate mofetil treatment of steroid-resistant idiopathic sclerosing orbital inflammation.

Patel AK, Hoch S, Shindler KS.

Clin Exp Ophthalmol. 2011 Dec;39(9):912-3. doi: 10.1111/j.1442-9071.2011.02561.x. Epub 2011 Apr 27. No abstract available.

PMID:
22128811
38.

Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis.

Quinn TA, Dutt M, Shindler KS.

Front Neurol. 2011 Aug 2;2:50. doi: 10.3389/fneur.2011.00050. eCollection 2011.

39.

The human visual cortex responds to gene therapy-mediated recovery of retinal function.

Ashtari M, Cyckowski LL, Monroe JF, Marshall KA, Chung DC, Auricchio A, Simonelli F, Leroy BP, Maguire AM, Shindler KS, Bennett J.

J Clin Invest. 2011 Jun;121(6):2160-8. doi: 10.1172/JCI57377. Epub 2011 May 23. Erratum in: J Clin Invest. 2011 Jul 1;121(7):2945.

40.

Macrophage-mediated optic neuritis induced by retrograde axonal transport of spike gene recombinant mouse hepatitis virus.

Shindler KS, Chatterjee D, Biswas K, Goyal A, Dutt M, Nassrallah M, Khan RS, Das Sarma J.

J Neuropathol Exp Neurol. 2011 Jun;70(6):470-80. doi: 10.1097/NEN.0b013e31821da499.

41.

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

Shindler KS, Ventura E, Dutt M, Elliott P, Fitzgerald DC, Rostami A.

J Neuroophthalmol. 2010 Dec;30(4):328-39. doi: 10.1097/WNO.0b013e3181f7f833.

42.

Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.

Wu GF, Shindler KS, Allenspach EJ, Stephen TL, Thomas HL, Mikesell RJ, Cross AH, Laufer TM.

J Autoimmun. 2011 Feb;36(1):56-64. doi: 10.1016/j.jaut.2010.10.006. Epub 2010 Nov 20.

43.

Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.

Simonelli F, Maguire AM, Testa F, Pierce EA, Mingozzi F, Bennicelli JL, Rossi S, Marshall K, Banfi S, Surace EM, Sun J, Redmond TM, Zhu X, Shindler KS, Ying GS, Ziviello C, Acerra C, Wright JF, McDonnell JW, High KA, Bennett J, Auricchio A.

Mol Ther. 2010 Mar;18(3):643-50. doi: 10.1038/mt.2009.277. Epub 2009 Dec 1.

44.

Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.

Dutt M, Tabuena P, Ventura E, Rostami A, Shindler KS.

Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1439-45. doi: 10.1167/iovs.09-4009. Epub 2009 Nov 5.

45.

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

Maguire AM, High KA, Auricchio A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli JL, Ying GS, Rossi S, Fulton A, Marshall KA, Banfi S, Chung DC, Morgan JI, Hauck B, Zelenaia O, Zhu X, Raffini L, Coppieters F, De Baere E, Shindler KS, Volpe NJ, Surace EM, Acerra C, Lyubarsky A, Redmond TM, Stone E, Sun J, McDonnell JW, Leroy BP, Simonelli F, Bennett J.

Lancet. 2009 Nov 7;374(9701):1597-605. doi: 10.1016/S0140-6736(09)61836-5. Epub 2009 Oct 23. Erratum in: Lancet. 2010 Jan 2;375(9708):30.

46.

Mechanisms of primary axonal damage in a viral model of multiple sclerosis.

Das Sarma J, Kenyon LC, Hingley ST, Shindler KS.

J Neurosci. 2009 Aug 19;29(33):10272-80. doi: 10.1523/JNEUROSCI.1975-09.2009.

47.

Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis.

Das Sarma J, Ciric B, Marek R, Sadhukhan S, Caruso ML, Shafagh J, Fitzgerald DC, Shindler KS, Rostami A.

J Neuroinflammation. 2009 Apr 28;6:14. doi: 10.1186/1742-2094-6-14.

48.

Annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) Fort Lauderdale, April 27-May 1, 2008.

Pomeranz HD, Mudumbai R, Shindler KS.

J Neuroophthalmol. 2008 Dec;28(4):348-51. doi: 10.1097/WNO.0b013e31818cba79. No abstract available.

PMID:
19145138
49.

Retinal ganglion cell loss in diabetes associated with elevated homocysteine.

Shindler KS.

Ophthalmol Eye Dis. 2009 Nov 17;1:41-3. Print 2009.

50.

Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.

Shindler KS, Ventura E, Dutt M, Rostami A.

Exp Eye Res. 2008 Sep;87(3):208-13. doi: 10.1016/j.exer.2008.05.017. Epub 2008 Jun 3.

Supplemental Content

Loading ...
Support Center